|
US4639433A
(en)
|
1985-08-14 |
1987-01-27 |
Eli Lilly And Company |
Glycopeptide derivatives
|
|
PT86457B
(pt)
*
|
1986-12-30 |
1990-11-20 |
Smithkline Beecham Corp |
Processo para a preparacao de glicopeptidos glicosilados e de composicoes que os contem
|
|
IT1228459B
(it)
|
1989-02-23 |
1991-06-19 |
Phidea S R L |
Inalatore con svuotamento regolare e completo della capsula.
|
|
US5785049A
(en)
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
|
PT101450B
(pt)
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
AU5806898A
(en)
|
1996-12-31 |
1998-07-31 |
Inhale Therapeutic Systems |
Processes and compositions for spray drying hydrophobic drugs in organic solventsuspensions of hydrophilic excipients
|
|
WO1999016420A1
(en)
|
1997-09-29 |
1999-04-08 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in nebulizers
|
|
NZ503464A
(en)
|
1997-09-29 |
2002-05-31 |
Inhale Therapeutic Syst |
Perforated microparticles containing a bioactive agent for pulmonary delivery
|
|
US6518242B1
(en)
*
|
1998-02-20 |
2003-02-11 |
Theravance, Inc. |
Derivatives of glycopeptide antibacterial agents
|
|
EP1085846A2
(en)
*
|
1998-06-08 |
2001-03-28 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
UA73924C2
(en)
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
ES2201825T3
(es)
|
1998-12-23 |
2004-03-16 |
Theravance, Inc. |
Derivados del glicopeptidos y composiciones farmaceuticas que los contienen.
|
|
JP4377076B2
(ja)
|
1999-05-28 |
2009-12-02 |
ネクター セラピューティクス |
噴霧化された薬物の計量された量を投与する装置と方法
|
|
US6606992B1
(en)
|
1999-06-30 |
2003-08-19 |
Nektar Therapeutics |
Systems and methods for aerosolizing pharmaceutical formulations
|
|
US6586008B1
(en)
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
|
WO2001057071A2
(en)
|
2000-02-04 |
2001-08-09 |
Advanced Medicine, Inc. |
Glycopeptide derivatives having antibiotic activity
|
|
WO2001058933A2
(en)
|
2000-02-11 |
2001-08-16 |
Eli Lilly And Company |
Selective n-acylation of a82846 glycopeptide analogs
|
|
CA2382133C
(en)
|
2000-05-10 |
2010-11-23 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
|
UA75083C2
(uk)
|
2000-06-22 |
2006-03-15 |
Тераванс, Інк. |
Похідні глікопептидфосфонатів
|
|
TWI312785B
(en)
*
|
2001-08-24 |
2009-08-01 |
Theravance Inc |
Process for preparing vancomycin derivatives
|
|
US7273845B2
(en)
|
2002-11-12 |
2007-09-25 |
Enzon Pharmaceuticals, Inc. |
Polymeric prodrugs of vancomycin
|
|
JP2006528704A
(ja)
|
2003-05-27 |
2006-12-21 |
セラヴァンス インコーポレーテッド |
グリコペプチド抗細菌剤と組み合わせたポリエンマクロライド抗真菌剤の使用
|
|
TWI342312B
(en)
*
|
2003-10-22 |
2011-05-21 |
Theravance Inc |
Hydrochloride salts of a glycopeptide phosphonate derivative
|
|
US7632918B2
(en)
*
|
2005-02-28 |
2009-12-15 |
Novartis Vaccines And Diagnostics, Inc. |
Semi-synthetic glycopeptides with antibiotic activity
|
|
US20070185015A1
(en)
*
|
2005-02-28 |
2007-08-09 |
Chiron Corporation and North China Pharmaceutical Corporation |
Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
|
|
JP2010540526A
(ja)
|
2007-09-25 |
2010-12-24 |
ノバルティス アーゲー |
エアロゾル化されたバンコマイシンのような薬剤での肺障害の処置
|
|
EP2214645A4
(en)
*
|
2007-10-23 |
2013-09-25 |
Transave Inc |
LIPOSOMAL VANCOMYCIN PREPARATIONS
|
|
WO2009085562A1
(en)
*
|
2007-12-26 |
2009-07-09 |
Lead Therapeutics, Inc. |
Novel semi-synthetic glycopeptides as antibacterial agents
|
|
WO2010048340A2
(en)
*
|
2008-10-24 |
2010-04-29 |
Lead Therapeutics, Inc. |
Novel semi-synthetic glycopeptides as antibacterial agents
|
|
GB2465863A
(en)
*
|
2008-12-05 |
2010-06-09 |
Lead Therapeutics Inc |
Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
|
|
JP2012522009A
(ja)
*
|
2009-03-26 |
2012-09-20 |
パルマトリックス，インコーポレイテッド |
肺炎および人工呼吸器関連気管気管支炎を治療および予防するための方法
|
|
CN102573882A
(zh)
*
|
2009-04-28 |
2012-07-11 |
塔尔甘塔治疗公司 |
用奥利万星治疗细菌感染的方法
|
|
BR112013029803B1
(pt)
*
|
2011-05-19 |
2021-07-13 |
Savara, Inc |
Composições de vancomicina em pó seco
|
|
US9572774B2
(en)
*
|
2011-05-19 |
2017-02-21 |
Savara Inc. |
Dry powder vancomycin compositions and associated methods
|
|
JP6254525B2
(ja)
|
2011-08-05 |
2017-12-27 |
ザ スクリプス リサーチ インスティテュート |
バンコマイシン耐性菌株に対して有効なグリコペプチド系抗生物質類似体
|
|
CN104349783B
(zh)
*
|
2012-05-21 |
2018-07-13 |
英斯麦德公司 |
治疗肺部感染的系统
|
|
WO2014085526A1
(en)
|
2012-11-29 |
2014-06-05 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
|
GB201402267D0
(en)
*
|
2014-02-10 |
2014-03-26 |
Cambridge Entpr Ltd |
Antibacterial agents
|
|
CN105085636B
(zh)
*
|
2014-05-19 |
2020-05-01 |
中国医学科学院药物研究所 |
一类万古霉素衍生物、其制备方法及其在抗菌方面的应用
|
|
US10577395B2
(en)
|
2014-07-10 |
2020-03-03 |
The Scripps Research Institute |
N-(hydrophobe-substituted) vancosaminyl [Ψ-[C(=NH) NH] Tpg4] vancomycin and [Ψ-[CH2NH]Tpg4] vancomycin
|
|
CN107325159A
(zh)
|
2016-04-29 |
2017-11-07 |
中国科学院上海药物研究所 |
一类万古霉素衍生物、其制备方法、药物组合物和用途
|
|
WO2018008197A1
(ja)
|
2016-07-07 |
2018-01-11 |
日東電工株式会社 |
反射層および蛍光体層付光半導体素子
|
|
JP7104424B2
(ja)
|
2016-10-31 |
2022-07-21 |
ザ スクリプス リサーチ インスティテュート |
相乗的に抗菌効力及び耐久性を改善するポケット再設計バンコマイシン類似体への末梢修飾
|
|
CA3062570A1
(en)
|
2017-05-22 |
2018-11-29 |
Insmed Incorporated |
Lipo-glycopeptide cleavable derivatives and uses thereof
|